Pb-203 labeled DOTA-ReCCMSH targeted alpha particle-emitting radionuclides (AlphaMed/University of Missouri)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePb-203 labeled DOTA-ReCCMSH targeted alpha particle-emitting radionuclides (AlphaMed/University of Missouri)
Drug Alias Nameradiolabeled CCMSH (University of Missouri)203Pb-DOTA-ReCCMSH (University of Missouri-Columbia)
ClassificationBiologics > Protein drugs > Recombinant polypeptideRadiation-emitting products > Radioactive therapeutic agentDiagnostic agent (In vivo)
Mechanisms of ActionMelanocortin receptor 1 modulators
TargetsMelanocortin receptor 1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Missouri
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlphaMed IncUniversity Of Missouri
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A